UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,949 | -32.8% | 115,057 | 0.0% | 0.00% | – |
| Q2 2023 | $147,273 | -39.0% | 115,057 | 0.0% | 0.00% | – |
| Q1 2023 | $241,620 | +1871.6% | 115,057 | +407.0% | 0.00% | – |
| Q4 2022 | $12,255 | -5.7% | 22,695 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -31.6% | 22,695 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -34.5% | 22,695 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | -38.3% | 22,695 | 0.0% | 0.00% | – |
| Q4 2021 | $47,000 | – | 22,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,470,152 | $2,984,331 | 0.33% |
| Nantahala Capital Management | 3,470,541 | $2,984,666 | 0.26% |
| BVF INC/IL | 3,413,563 | $2,935,664 | 0.08% |
| RA Capital Management | 3,470,688 | $2,984,792 | 0.06% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 31,000 | $26,660 | 0.01% |
| Virtu Financial LLC | 10,994 | $9 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,399 | $45,063 | 0.00% |
| STATE STREET CORP | 35,036 | $30,131 | 0.00% |
| GOLDMAN SACHS GROUP INC | 93,233 | $80,180 | 0.00% |